세계의 레이저 캡처 현미해부 시장 : 제품, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Laser Capture Microdissection Market was valued at USD 165.94 million in 2023, expected to reach USD 176.14 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 257.20 million by 2030.

Laser capture microdissection (LCM) is a pivotal technology in molecular biology, allowing for the precise isolation of specific cells or tissue sections from a heterogeneous sample under microscopic visualization. This capability is necessary for applications requiring high purity of samples for genomic, transcriptomic, proteomic, and metabolomic studies. Its end-use spans clinical research, pathology, forensics, and personalized medicine, providing a deep dive into cellular heterogeneity within diseases such as cancer, neurological disorders, and infectious diseases. Key growth factors influencing the LCM market include the increasing demand for personalized medicine, advancements in molecular diagnostics, and the push for precision in research methodologies. Recent years have seen a rise in the adoption of LCM in single-cell analysis and biomarker discovery, highlighting significant opportunities for market players specializing in high-resolution imaging and sample preparation technologies. To leverage these opportunities, companies should focus on improving user interface technology, enhancing the accuracy and speed of dissection, and developing complementary software for data analysis. However, several limitations could impede market growth, including the high costs of LCM equipment, technical complexity requiring skilled personnel, and the dependence on downstream analysis techniques, which may not always yield reproducible results. These challenges necessitate a focus on training programs and partnerships with academic and research institutes to expand the user base and enhance technology usability. The areas ripe for innovation include the integration of artificial intelligence in LCM to automate and enhance image recognition and sample selection processes, as well as the development of portable and affordable LCM systems to widen accessibility. The nature of the LCM market remains competitive, with continuous technological advancements and periodic mergers and acquisitions to consolidate market presence and foster collaborative innovation among industry stakeholders, driving growth and enhancing usability in achieving unprecedented levels of precision in cell and tissue research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Laser Capture Microdissection Market

The Laser Capture Microdissection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cancer and other chronic diseases
  • Increasing advancement in molecular biology and its applications in genomic and proteomic studies
• Market Restraints
  • Expenses associated with the procurement and operation of LCM systems
• Market Opportunities
  • Integration of LCM with next-generation sequencing and other molecular analysis methods
  • Ongoing investments in research and development
• Market Challenges
  • Presence of alternative cell isolation techniques, such as flow cytometry and magnetic-activated cell sorting (MACS)

Porter's Five Forces: A Strategic Tool for Navigating the Laser Capture Microdissection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Laser Capture Microdissection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Laser Capture Microdissection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Laser Capture Microdissection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Laser Capture Microdissection Market

A detailed market share analysis in the Laser Capture Microdissection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Laser Capture Microdissection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Laser Capture Microdissection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Laser Capture Microdissection Market

A strategic analysis of the Laser Capture Microdissection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Laser Capture Microdissection Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Agilent Technologies, Inc., AnaPath Services GmbH, Bio-Rad Laboratories, Inc., CaresBio Laboratory, Carl Zeiss AG, Crown Bioscience, Danaher Corporation, DeNova Sciences, DSS Imagetech Pvt. Ltd., Epistem Ltd., F. Hoffmann-La Roche AG, GE HealthCare, Gnome Diagnostics, LLC, HUBNER Group, Molecular Machines & Industries GmbH, Ocimum Biosolutions, Standard BioTools Inc., Thermo Fisher Scientific Inc., and VitroVivo Biotech LLC.

Market Segmentation & Coverage

This research report categorizes the Laser Capture Microdissection Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instruments, and Software & Services. The Consumables is further studied across Assay Kits and Reagents & Media.
• Based on Technique, market is studied across Immune Laser Capture, Infrared Laser Microdissection, and UV Laser Microdissection.
• Based on Application, market is studied across Cell Biology, Diagnostics, Forensic Science, Molecular Biology, Personalized Medicine, and Research & Development.
• Based on End-user, market is studied across Academic & Government Research Institutes, Contract Research Organizations (CROS), Hospitals, and Pharmaceutical & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cancer and other chronic diseases
    • 5.1.1.2. Increasing advancement in molecular biology and its applications in genomic and proteomic studies
  • 5.1.2. Restraints
    • 5.1.2.1. Expenses associated with the procurement and operation of LCM systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of LCM with next-generation sequencing and other molecular analysis methods
    • 5.1.3.2. Ongoing investments in research and development
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of alternative cell isolation techniques, such as flow cytometry and magnetic-activated cell sorting (MACS)
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing adoption of laser capture microdissection instruments owing to their precision in isolating specific cells for detailed molecular analysis
  • 5.2.2. Application: Widening application in diagnostics to isolate diseased cells directly from tissues, enabling the detection and analysis of disease markers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Laser Capture Microdissection Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Reagents & Media
• 6.3. Instruments
• 6.4. Software & Services

7. Laser Capture Microdissection Market, by Technique

• 7.1. Introduction
• 7.2. Immune Laser Capture
• 7.3. Infrared Laser Microdissection
• 7.4. UV Laser Microdissection

8. Laser Capture Microdissection Market, by Application

• 8.1. Introduction
• 8.2. Cell Biology
• 8.3. Diagnostics
• 8.4. Forensic Science
• 8.5. Molecular Biology
• 8.6. Personalized Medicine
• 8.7. Research & Development

9. Laser Capture Microdissection Market, by End-user

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Contract Research Organizations (CROS)
• 9.4. Hospitals
• 9.5. Pharmaceutical & Biotech Companies

10. Americas Laser Capture Microdissection Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Laser Capture Microdissection Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Laser Capture Microdissection Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. A New Insight into Colorectal Tumors' Immune Evasion Strategies from Vanderbilt Researchers
  • 13.3.2. Laxco Inc. launched the Accuva Cellect Laser Capture Microdissection System
  • 13.3.3. Thermo Fisher Scientific Entered into an Agreement with Laxco Inc. for the global commercialization of the Arcturus Cellect LCM system
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3DHISTECH Ltd.
• 2. Agilent Technologies, Inc.
• 3. AnaPath Services GmbH
• 4. Bio-Rad Laboratories, Inc.
• 5. CaresBio Laboratory
• 6. Carl Zeiss AG
• 7. Crown Bioscience
• 8. Danaher Corporation
• 9. DeNova Sciences
• 10. DSS Imagetech Pvt. Ltd.
• 11. Epistem Ltd.
• 12. F. Hoffmann-La Roche AG
• 13. GE HealthCare
• 14. Gnome Diagnostics, LLC
• 15. HUBNER Group
• 16. Molecular Machines & Industries GmbH
• 17. Ocimum Biosolutions
• 18. Standard BioTools Inc.
• 19. Thermo Fisher Scientific Inc.
• 20. VitroVivo Biotech LLC